Myriad Genetics Inc (MYGN)

EBITDA

-$26.00M

Quarterly · Period ending: · USD

MYGN logo

MYGN EBITDA

Latest reported-$26.00M
MYGN Quarterly EBITDA ($1.00M → -$26.00M)
High-resolution chart · PNG

MYGN ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-26,000,000
-17,500,000
8,100,000
-9,800,000
-315,000,000
-14,200,000
-23,600,000
-4,800,000
-21,300,000
-9,700,000
-16,300,000
-46,100,000
-102,300,000
-32,700,000
-37,500,000
-30,300,000
-4,400,000
-12,500,000
-29,700,000
55,100,000
15,100,000
-28,200,000
18,100,000
-23,100,000
-37,700,000
-110,900,000
9,300,000
-1,200,000
13,900,000
24,800,000
25,000,000
21,300,000
26,300,000
26,800,000
19,400,000
97,300,000
33,300,000
22,400,000
27,600,000
13,900,000
42,300,000
49,600,000
51,800,000
50,100,000
42,809,000
42,100,000
42,300,000
31,900,000
58,782,000
58,767,000
85,438,000
85,276,000
68,170,000
60,098,000
57,830,000
50,793,000
49,614,000
48,399,000
47,756,000
43,619,000
43,655,000
43,624,000
40,370,000
37,348,000
39,407,000
35,003,000
36,257,000
31,491,000
75,512,000
37,668,000
35,663,000
15,568,000
68,473,000
-5,529,000
-6,569,000
-9,514,000
-10,258,000
-7,137,000
13,193,000
-13,243,000
-12,177,000
-10,237,000
-7,909,000
-8,410,000
-7,195,000
-9,187,000
-9,139,000
-9,131,000
-9,463,000
-9,711,000
-8,946,000
-8,749,000
-6,368,000
-4,817,000
-6,110,000
-4,776,000
-6,246,769
-3,233,590
-2,758,039
-1,925,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.